News
Investment Thesis StoneCo’s (NASDAQ:STNE) stock price has been range-bound for most of the past couple of years. However, the business has continued to grow,...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
Civitas Resources, Inc. (NYSE:CIVI) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Brad Whitmarsh – Head, Investor Relations Chris...
News
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
News
This article was written by Follow Fidelity’s mission is to strengthen the financial well-being of our customers and deliver better outcomes for the clients...
News
Consumer bankruptcies steadily increased during August in another sign that financial distress is increasing for many people. Americans filed more than 39,000 bankruptcy cases...
News
Akoustis Technologies, Inc. (NASDAQ:AKTS) Q4 2023 Earnings Conference Call September 6, 2023 8:00 AM ET Company Participants Tom Sepenzis – Investor Relations Jeff Shealy...
News
I spent an afternoon recently researching how parents can deal with the sticker shock of adding a new teen driver to their car-insurance policy,...
News
Do you get calls from a debt collection agency? Having delinquent debt not only hurts your chances of getting a loan but can also...
News
Financial markets have had a bumpy ride lately, inspiring fresh concerns that this year’s rebound from 2022’s sharp loss has run its course. It’s...
News
The retirement savings landscape experienced a radical transformation with the enactment of the SECURE Act 2.0 at the end of 2022. This groundbreaking legislation...
News
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands...
News
This is reprinted by permission from . Making money, whether by putting cash into the stock market, buying a home or jumping to a...
News
Recombinant therapeutic protein developer, Protalix BioTherapeutics, Inc. (NYSE:PLX) reported Q2 2023 revenues of $35.08 million, representing a 300.72% (YoY) increase. It beat Wall Street...
